Clinical Trials Directory

Trials / Completed

CompletedNCT01599611

Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study

Status
Completed
Phase
Study type
Observational
Enrollment
128 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
5 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The objective of this study was to investigate whether infants with total serum bilirubin \> 450 umol/L in the neonatal period and no symptoms or no more than early acute bilirubin encephalopathy develop long term sequelae with impairment of motor development, hearing and executive function compared with a control group.

Detailed description

Children in both the exposed and the non-exposed group were examined by use of the MABC-2 and pure tone audiometry by the responsible examiner for the study, Pernille Vandborg, MD. The aim was to see whether the exposed group suffered any long term sequelae to the extreme neonatal hyperbilirubinemia, i.e. impaired motor development or hearing impairment, compared to a control group. The examinations took place at the local hospital.

Conditions

Interventions

TypeNameDescription
PROCEDUREMovement assessment battery for children - 2A standardised test developed to identify developmental difficulties in children.

Timeline

Start date
2010-03-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2012-05-16
Last updated
2012-05-16

Source: ClinicalTrials.gov record NCT01599611. Inclusion in this directory is not an endorsement.